Table 3. Plasma proteomic and C-reactive protein (CRP) analyses stratified by users and non-users of hormonal contraception in three ethnocultural groups (Whites, East Asians and South Asians/Other).
WHITES | EAST ASIANS | SOUTH ASIANS + OTHER | ||||||||
Non-Users (n = 209) | Users (n = 166) | Non-Users (n = 243) | Users (n = 39) | Non-Users (n = 91) | Users(n = 35) | |||||
Plasma Protein (μmol/L) | Mean±SE‡ | Mean±SE‡ | p-value† * | Mean±SE‡ | Mean±SE‡ | p-value† * | Mean±SE‡ | Mean±SE‡ | p-value† * | DIRECTION relative to users |
α1-Antitrypsin | 10.58±0.17 | 14.52±0.27 | <.0001 | 10.04±0.13 | 12.78±0.42 | <.0001 | 11.15±0.25 | 14.08±0.48 | <.0001 | higher in users |
Angiotensinogen | 0.71±0.02 | 2.13±0.07 | <.0001 | 0.67±0.01 | 1.76±0.13 | <.0001 | 0.69±0.03 | 2.15±0.15 | <.0001 | higher in users |
α2-HS-Glycoprotein | 8.39±0.15 | 10.32±0.18 | <.0001 | 8.31±0.1 | 9.56±0.32 | 0.0003 | 8.62±0.20 | 10.63±0.37 | <.0001 | higher in users |
Apolipoprotein A-I | 43.41±0.63 | 50.57±0.81 | <.0001 | 43.99±0.62 | 50.66±1.61 | 0.0004 | 41.2±0.95 | 51.89±1.96 | <.0001 | higher in users |
Apolipoprotein A-II Precursor | 23.66±0.36 | 30.19±0.45 | <.0001 | 23.61±0.31 | 29.35±0.98 | <.0001 | 23.10±0.51 | 31.31±1.25 | <.0001 | higher in users |
Apolipoprotein L1 | 0.36±0.01 | 0.6±0.02 | <.0001 | 0.34±0.01 | 0.53±0.03 | <.0001 | 0.41±0.02 | 0.58±0.03 | <.0001 | higher in users |
C-Reactive Protein | 0.92±0.17 | 2.69±0.26 | <.0001 | 0.49±0.09 | 2.40±0.58 | <.0001 | 1.36±0.29 | 2.25±0.38 | <.0001 | higher in users |
Ceruloplasmin | 2.12±0.05 | 3.69±0.09 | <.0001 | 1.89±0.03 | 3.16±0.11 | <.0001 | 2.26±0.07 | 3.82±0.21 | <.0001 | higher in users |
D Vitamin Binding Protein | 2.69±0.04 | 3.7±0.07 | <.0001 | 2.56±0.03 | 3.38±0.11 | <.0001 | 2.68±0.05 | 3.63±0.13 | <.0001 | higher in users |
Coagulation Factor XIIa HC | 0.28±0.01 | 0.40±0.01 | <.0001 | 0.19±0.01 | 0.27±0.01 | <.0001 | 0.22±0.01 | 0.39±0.02 | <.0001 | higher in users |
Heparin Cofactor II | 0.67±0.01 | 0.88±0.02 | <.0001 | 0.63±0.01 | 0.76±0.03 | <.0001 | 0.72±0.02 | 0.86±0.04 | 0.0006 | higher in users |
Kininogen-1 | 2.05±0.03 | 2.79±0.05 | <.0001 | 1.94±0.02 | 2.46±0.07 | <.0001 | 2.00±0.05 | 2.76±0.13 | <.0001 | higher in users |
Plasminogen | 1.15±0.02 | 1.50±0.02 | <.0001 | 1.17±0.01 | 1.47±0.04 | <.0001 | 1.21±0.02 | 1.54±0.06 | <.0001 | higher in users |
Retinol-Binding Protein | 0.86±0.02 | 1.17±0.02 | <.0001 | 0.79±0.01 | 1.08±0.04 | <.0001 | 0.77±0.02 | 1.13±0.05 | <.0001 | higher in users |
Serum Amyloid P-Component | 0.38±0.01 | 0.51±0.01 | <.0001 | 0.35±0.01 | 0.56±0.03 | <.0001 | 0.43±0.02 | 0.53±0.03 | 0.0002 | higher in users |
Vitronectin | 3.53±0.05 | 4.65±0.08 | <.0001 | 3.46±0.04 | 4.32±0.11 | <.0001 | 3.70±0.08 | 4.69±0.17 | <.0001 | higher in users |
Apolipoprotein E | 0.5±0.01 | 0.43±0.01 | <.0001 | 0.58±0.01 | 0.47±0.02 | 0.0005 | 0.57±0.02 | 0.41±0.02 | <.0001 | lower in users |
Complement C1 Inactivator | 4.73±0.08 | 3.74±0.1 | <.0001 | 4.89±0.07 | 4.24±0.17 | 0.0006 | 5.04±0.12 | 3.92±0.24 | <.0001 | lower in users |
Histidine-rich Glycoprotein | 1.37±0.03 | 1.03±0.03 | <.0001 | 1.43±0.03 | 1.14±0.07 | <.0001 | 1.39±0.04 | 0.97±0.05 | <.0001 | lower in users |
Afamin | 0.24±0 | 0.29±0.01 | <.0001 | 0.25±0.01 | 0.27±0.01 | 0.1485 | 0.25±0.01 | 0.30±0.01 | <.0001 | |
α1-Acid Glycoprotein 1 | 1.97±0.05 | 1.59±0.04 | <.0001 | 1.55±0.03 | 1.42±0.09 | 0.1009 | 1.97±0.07 | 1.48±0.08 | <.0001 | |
Albumin | 965.89±11.35 | 890.33±10.53 | <.0001 | 976.09±9.52 | 896.57±12.8 | 0.0019 | 933.32±15.04 | 863.39±19.03 | 0.0157 | |
Apolipoprotein B-100 | 0.77 ± 0.02 | 0.93±0.02 | <.0001 | 0.75±0.01 | 0.80±0.03 | 0.1799 | 0.77±0.03 | 0.95±0.04 | 0.0006 | |
Apolipoprotein C-III | 2.28±0.05 | 3.05±0.07 | <.0001 | 2.32±0.05 | 2.80±0.13 | 0.0011 | 2.16±0.09 | 2.89±0.15 | <.0001 | |
Complement C3 | 18.98±0.32 | 21.86±0.35 | <.0001 | 17.75±0.24 | 20.13±0.56 | 0.0011 | 21.10±0.59 | 22.44±0.85 | 0.1815 | |
Complement Factor B | 1.41±0.03 | 1.57±0.03 | <.0001 | 1.3±0.02 | 1.56±0.07 | 0.0002 | 1.66±0.05 | 1.66±0.06 | 0.8341 | |
Complement Factor H | 0.60±0.01 | 0.65±0.01 | <.0001 | 0.53±0.01 | 0.57±0.02 | 0.0418 | 0.66±0.02 | 0.66±0.02 | 0.6789 | |
Clusterin | 1.5±0.02 | 1.64±0.03 | <.0001 | 1.5±0.02 | 1.63±0.04 | 0.0117 | 1.52±0.03 | 1.68±0.06 | 0.0188 | |
Hemopexin | 10.44±0.15 | 11.44±0.16 | <.0001 | 9.53±0.13 | 10.71±0.24 | 0.0014 | 10.61±0.24 | 11.25±0.41 | 0.1937 | |
Inter- α-Trypsin Inhibitor HC | 0.60±0.01 | 0.67±0.01 | <.0001 | 0.62±0.01 | 0.68±0.02 | 0.0059 | 0.62±0.01 | 0.69±0.02 | 0.0028 | |
Prothrombin | 0.56±0.01 | 0.62±0.01 | <.0001 | 0.57±0.01 | 0.61±0.01 | 0.0641 | 0.58±0.01 | 0.60±0.02 | 0.6427 | |
Transferrin | 12.41±0.21 | 14.57±0.25 | <.0001 | 11.99±0.18 | 13.18±0.39 | 0.008 | 13.01±0.35 | 15.39±0.55 | 0.0003 | |
Transthyretin | 5.38±0.09 | 5.97±0.09 | <.0001 | 5.41±0.08 | 5.98±0.17 | 0.0064 | 4.97±0.11 | 5.84±0.21 | 0.0003 | |
Apolipoprotein A-IV | 1.49±0.03 | 1.34±0.03 | 0.0001 | 1.32±0.02 | 1.29±0.05 | 0.7936 | 1.41±0.05 | 1.26±0.07 | 0.0649 | |
Antithrombin-III | 3.59±0.05 | 3.38±0.04 | 0.0008 | 3.61±0.04 | 3.31±0.07 | 0.0098 | 3.54±0.06 | 3.30±0.09 | 0.0292 | |
α1B-Glycoprotein | 1.72±0.03 | 1.89±0.05 | 0.002 | 1.62±0.03 | 1.78±0.09 | 0.0864 | 1.64±0.06 | 1.84 ± 0.12 | 0.122 | |
Apolipoprotein C-I | 3.31±0.07 | 3.51±0.06 | 0.0074 | 3.18±0.05 | 3.43±0.14 | 0.1587 | 3.13±0.10 | 3.36±0.13 | 0.1626 | |
L-Selectin | 0.08±0 | 0.07±0 | 0.0089 | 0.07±0.01 | 0.06±0.01 | 0.0059 | 0.07±0.01 | 0.07±0.01 | 0.0537 | |
Fibrinogen γ Chain | 9.54±0.3 | 10.27±0.34 | 0.0139 | 9.46±0.24 | 11.09±1.23 | 0.1462 | 10.13±0.38 | 10.61±0.5 | 0.3454 | |
Fibrinogen β Chain | 9.59±0.26 | 10.27±0.33 | 0.0192 | 9.49±0.23 | 10.71±0.97 | 0.1513 | 10.06±0.33 | 11.1±0.58 | 0.1364 | |
Fibrinogen α Chain | 11.99±0.38 | 12.94±0.49 | 0.0205 | 12.01±0.33 | 14.25±1.88 | 0.1225 | 12.36±0.44 | 13.9±0.72 | 0.0979 | |
Fibrinopeptide A | 7.17±0.19 | 7.56±0.21 | 0.0305 | 6.99±0.16 | 8.07±0.85 | 0.1418 | 7.60±0.24 | 8.09±0.38 | 0.3526 | |
Gelsolin, isoform 1 | 1.19±0.02 | 1.11±0.02 | 0.0343 | 1.17±0.02 | 1.05±0.04 | 0.0005 | 1.21±0.03 | 1.18±0.05 | 0.6169 | |
α2-Antiplasmin | 1.92±0.03 | 1.99±0.03 | 0.0344 | 1.91±0.03 | 1.95±0.04 | 0.369 | 1.93±0.04 | 2.03±0.07 | 0.2039 | |
Zinc- α2-Glycoprotein | 1.02±0.03 | 1.08±0.03 | 0.0561 | 0.96±0.02 | 1.04±0.05 | 0.233 | 1.01±0.04 | 1.09±0.06 | 0.2064 | |
α2-Macroglobulin | 6.1±0.12 | 5.92±0.15 | 0.0972 | 6.19±0.1 | 5.79±0.19 | 0.2542 | 6.25±0.18 | 6.03±0.22 | 0.7205 | |
α1-Antichymotrypsin | 3.5±0.06 | 3.35±0.06 | 0.1129 | 3.22±0.05 | 3.19±0.1 | 0.8063 | 3.63±0.09 | 3.17±0.13 | 0.0016 | |
Apolipoprotein D | 0.35±0.01 | 0.34±0.01 | 0.1283 | 0.33±0.01 | 0.32±0.01 | 0.4027 | 0.36±0.01 | 0.33±0.01 | 0.0988 | |
Complement C9 | 2.8±0.05 | 2.69±0.06 | 0.1585 | 2.71±0.05 | 2.84±0.16 | 0.6286 | 3.17±0.10 | 2.60±0.10 | 0.0017 | |
Complement C4 β Chain | 1.36±0.03 | 1.4±0.04 | 0.1646 | 1.36±0.03 | 1.38±0.08 | 0.9182 | 1.66±0.07 | 1.65±0.12 | 0.9227 | |
Complement C4 γ Chain | 1.49±0.03 | 1.53±0.04 | 0.2421 | 1.51±0.04 | 1.51±0.08 | 0.7504 | 1.83±0.08 | 1.85±0.13 | 0.904 | |
Adiponectin | 0.08±0 | 0.07±0 | 0.2474 | 0.06±0.01 | 0.06±0.01 | 0.6549 | 0.06±0.01 | 0.06±0.01 | 0.5314 | |
Fibronectin | 0.65±0.08 | 0.62±0.1 | 0.4056 | 0.59±0.07 | 0.73±0.22 | 0.8263 | 0.50±0.04 | 0.65±0.10 | 0.5252 | |
Haptoglobin β Chain | 11±0.35 | 10.45±0.36 | 0.6736 | 9.86±0.32 | 9.21±0.91 | 0.3018 | 13.38±0.70 | 9.48±1.09 | <.0001 | |
β2-Glycoprotein I | 2.83±0.05 | 2.80±0.05 | 0.8658 | 2.62±0.03 | 2.61±0.06 | 0.9237 | 2.77±0.06 | 2.73±0.14 | 0.5768 |
Bold and Italic = Significant at the Bonferroni level; Italic = significant but not at the Bonferroni level.
Adjusted for age, waist circumference and physical activity.
Untransformed, log transformed or square route transformed.
Unadjusted and untransformed means and standard errors.